Argenx Se (ARGX) Net Income (2016 - 2026)
Argenx Se's (ARGX) quarterly Net Income came in at $601.0 million in Q2 2026, up 82.99% on a YoY basis from $328.4 million in Q2 2025, and up 20.44% quarter-over-quarter from $499.0 million in Q1 2026.
Powered by 
Analysis
Argenx Se (ARGX) Net Income (2016 - 2026) Analysis & Trends
Argenx Se (ARGX) has reported Net Income for 11 consecutive years, with $601.0 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Income rose 82.99% year-over-year to $601.0 million; the trailing twelve-month figure through Jun 2026 stood at $1.8 billion (up 3935.77% YoY), and the FY2025 full-year result was $1.3 billion, up 290.92% from the prior year.
- Net Income climbed to $601.0 million in Q2 2026 per ARGX's latest filing, from $499.0 million in the prior quarter.
- Across five years, Net Income topped out at $601.0 million in Q2 2026 and bottomed at -$603.8 million in Q4 2024.
- Historically, Net Income has averaged $35.4 million across 5 years, with a median of -$51.5 million in 2022.
- The sharpest annual moves came in 2024 and 2025: Net Income sank 2504.39% in 2024, then surged 656.0% in 2025.
- Over 5 years, Net Income stood at -$43.9 million in 2022, then surged by 47.14% to -$23.2 million in 2023, then tumbled by 2504.39% to -$603.8 million in 2024, then surged by 145.32% to $273.6 million in 2025, then soared by 119.63% to $601.0 million in 2026.
- According to Business Quant data, Net Income over the past three periods registered $601.0 million, $499.0 million, and $273.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn | -238.00 Mn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Argenx Se | 58.53 Bn | 53.35 Bn | 1.37 Bn | 601.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 601.00 Mn |
| Mar 31, 2026 | 499.00 Mn |
| Dec 31, 2025 | 273.64 Mn |
| Sep 30, 2025 | 427.85 Mn |
| Jun 30, 2025 | 328.44 Mn |
| Mar 31, 2025 | 235.36 Mn |
| Dec 31, 2024 | -603.80 Mn |
| Sep 30, 2024 | 84.64 Mn |
| Jun 30, 2024 | -59.07 Mn |
| Mar 31, 2024 | -87.10 Mn |
| Dec 31, 2023 | -23.18 Mn |
| Sep 30, 2023 | -93.92 Mn |
| Jun 30, 2023 | -73.35 Mn |
| Mar 31, 2023 | -123.49 Mn |
| Dec 31, 2022 | -43.86 Mn |
| Sep 30, 2022 | -247.01 Mn |
| Jun 30, 2022 | -225.21 Mn |
| Mar 31, 2022 | -232.96 Mn |
| Dec 31, 2021 | -251.94 Mn |
| Sep 30, 2021 | -228.12 Mn |
API Access
Argenx Se Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=ARGX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "ARGX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=ARGX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();